Biotech

All Articles

Boundless Bio makes 'small' layoffs 5 months after $100M IPO

.Only five months after safeguarding a $100 million IPO, Boundless Bio is already giving up some wor...

Halda's $126M will evolve 'hold and eliminate' lump medicines

.The preliminary stages of oncology R&ampD aren't except interesting new techniques, and also Halda ...

Lykos 'regrets' certainly not making known research transgressions with publisher

.Psychopharmacology has drawn three write-ups about midstage medical trial data examining Lykos Reha...

Analysts explore Avidity's DMD gain, disclosing distinctions in data

.Avidity Biosciences satisfied entrepreneurs along with phase 1/2 records in Duchenne muscle dystrop...

Actinogen's cortisol blocker falls short phase 2 anxiety study

.Actinogen Medical's cortisol blocker has actually skipped the primary endpoint of a phase 2 researc...

Bivictrix chooses going private only technique to take ADC right into facility

.Antibody-drug conjugates (ADCs) have actually been at the facility of several a billion-dollar biob...

TPG tops up funds to $580M for investments throughout lifestyle scientific researches

.Asset manager TPG, which has supported biotechs including Sionna Rehabs and also Santa Clam Ana Bio...

Merck quits phase 3 TIGIT trial in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT system has actually experienced one more problem. Months after shuttering a ...

After a difficult year, Exscientia folds up in to Recursion

.After a year defined through pipeline cuts, the shift of its CEO and also unemployments, Exscientia...

Cullinan, after $25M deal, return bispecific to Port

.Cullinan Therapy was impressed sufficient along with Port BioMed's bispecific invulnerable reactor ...